Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was EGP 314.72 million compared to EGP 235.4 million a year ago. Net income was EGP 45.31 million compared to EGP 24.9 million a year ago. Basic earnings per share from continuing operations was EGP 0.0453 compared to EGP 0.0249 a year ago. For the nine months, sales was EGP 852.49 million compared to EGP 672.86 million a year ago. Net income was EGP 107.08 million compared to EGP 68.67 million a year ago. Basic earnings per share from continuing operations was EGP 0.1071 compared to EGP 0.0687 a year ago.